Your Daily Dose of BuzzFlash at Truthout, via my pal Mark Karlin:
Michelle Langbehn, 30, has a one-year-old daughter. She also has stage IV sarcoma, with a life expectancy of one year. That is unless she is able to beat the odds as a result of promising new treatment undergoing clinical trials at the National Institutes of Health (NIH).
But Langbehn, according to the Washington Post (WP), won't be receiving the treatment that she was scheduled for due to the House GOP not passing a new federal budget. The resultant cutbacks at NIH (for what are deemed non-essential services) have stopped clinical trials dead in their tracks. [...]
She has a message for Congress as she told the WP:
I want to tell them that lives are at stake. This isn't just a matter of inconvenience. This is a matter of life or death. I’m not just doing this for myself. There are 200 people that are trying to get into clinical trials each week. I want to speak for all of us.
RT online reports that some of the cancer patients denied clinical trial treatment are children [...]
There is no guarantee that the clinical trial Langbehn is being denied because of the House GOP government shutdown will prolong her life indefinitely, but it does provide a great deal of promise and hope -- to her young daughter and family.
"Lives are at stake," she told the WP -- and indeed they are.
Please read the entire post here.